**Core Concept**
Medullary carcinoma of the thyroid (MTC) is a malignant tumor originating from the parafollicular cells (C cells) of the thyroid gland. This type of cancer is associated with a specific genetic syndrome that predisposes individuals to develop MTC.

**Why the Correct Answer is Right**
The correct answer is associated with a genetic mutation in the RET proto-oncogene, which is a key component in the pathogenesis of medullary thyroid carcinoma. This mutation leads to the activation of the RET tyrosine kinase receptor, resulting in uncontrolled cell growth and tumor formation. The syndrome linked to MTC is characterized by the presence of multiple endocrine neoplasia type 2 (MEN 2), which includes MEN 2A and MEN 2B. MEN 2A is further divided into three subtypes: MEN 2A, MEN 2B, and familial MTC.

**Why Each Wrong Option is Incorrect**
**Option A:** MEN 1 syndrome is associated with tumors of the parathyroid glands, pituitary gland, and pancreas, but not specifically with medullary carcinoma of the thyroid.
**Option B:** MEN 4 is a rare syndrome that includes features of MEN 1 and MEN 2, but its association with MTC is not as well established as MEN 2.
**Option C:** Familial adenomatous polyposis (FAP) is a genetic disorder characterized by the development of hundreds to thousands of polyps in the colon, but it is not associated with medullary carcinoma of the thyroid.

**Clinical Pearl / High-Yield Fact**
MEN 2A and MEN 2B syndromes are inherited in an autosomal dominant pattern, meaning that a mutation in one of the two copies of the RET gene is sufficient to cause the disorder. Early detection and treatment of MTC can significantly improve patient outcomes.

**Correct Answer:** D. MEN 2